Catalyst Wire Dossier Catalyst Wire Dossier

HiLow Hyaluronic Acid

hyaluronic acid · IBSA Farmaceutici Italia Srl
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HiLow Hyaluronic Acid, covering 2025-01-08 to 2025-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Intralesional HiLow Hyaluronic Acid in the Treatment of Peyronie's Disease (PD) [NA]

See pricing